Literature DB >> 32582871

Characteristic Temporary Loss of Taste and Olfactory Senses in SARS-CoV-2-positive-Individuals with Mild Symptoms.

Ricarda M Schmithausen1,2, Manuel Döhla1,2, Heidrun Schöβler3, Christin Diegmann1, Bianca Schulte4, Enrico Richter4, Anna-Maria Eis-Hübinger4, Hendrik Streeck4.   

Abstract

Entities:  

Keywords:  COVID-19; Coronavirus; SARS-CoV-2; Symptoms

Year:  2020        PMID: 32582871      PMCID: PMC7307443          DOI: 10.20411/pai.v5i1.374

Source DB:  PubMed          Journal:  Pathog Immun        ISSN: 2469-2964


× No keyword cloud information.
SARS-CoV-2 infection has been characterized as an upper and lower respiratory tract infection with symptoms ranging from sore throat, cough, headache, and fatigue to a severe respiratory syndrome that requires intensive care [1-7]. Although a lower death rate has been recorded for SARS-CoV-2 in comparison to other recent coronavirus outbreaks, such as MERS or SARS, a compromised respiratory status on admission has been associated with fatal outcomes. Among the >1200 SARSCoV-2-infected individuals in Germany to date, many of the diagnosed persons show mild symptoms to no clinical signs of infection. Here we describe the onset and characteristics of symptoms in a cluster outbreak after a carnival celebration in a small town in the state of North Rhine-Westphalia currently contributing 43% of the total number of infected individuals in Germany to date [8]. Among the nearly 500 individuals in domestic quarantine as ordered by the Local Health Authority at that time, we interviewed 41 randomly selected individuals with qPCR confirmed SARS-CoV-2 infection. Inclusion criteria for the survey participation were: residents, positive for SARS-CoV-2 in pharyngeal swabs, ≥18 years of age, and confirmed informed consent. Median age was 40 years (IQR: 31-53, range: 18-82) and 51%were female. All persons examined had attended a carnival festivity also attended by the SARS-CoV-2positive index patient. All persons who attended this carnival festivity were tested for SARS-CoV-2 by the local health authorities 10 days later. Among survey participants, onset of symptoms began 12 days (IQR: 11-13) after probable infection and a median of 6 distinct symptoms (IQR: 4-8) were described. The most frequent symptom was a dry and persistent, non-productive cough, which was present in 30 individuals (73%). Interestingly, 12 (IQR: 12-14.5) days after probable infection, individuals described a disturbing loss of taste and/or olfactory sense (28 patients, 68%). Onset of dysosmia and dysgeusia was described as gradual, persisting for 3-5 days, and followed by a slow recovery. There was no association with any other symptoms, such as sore throat, runny nose, or headache. Dysosmia is also described for different viral infections (sinusitis, common cold), but also as a symptom of other diseases (stroke, drug abuse, tumors, craniocerebral trauma, toxin poisoning) [9]. Accordingly to our data, other recent studies also show that dysosmia could be an independent predictive symptom of COVID-19 [10-13]. Another common symptom was general fatigue (28 patients, 68%), followed by runny nose (21 patients, 51%), and headache and muscle/limb pain (18 patients each, 44%). Seventeen patients had fever (42%), 17 patients had a sore throat (42%), and one third described persistent diarrhea (13 patients, 32%), which was more frequent than in other reports. Although previous reports have mainly focused on moderate to severe symptoms, we describe here distinct and characteristic symptoms in individuals with only mild symptoms. Thus, our data suggest that individuals with a combination of a dry cough and loss of smell and/or taste should trigger diagnostic evaluation for SARS-CoV-2.
  8 in total

1.  Taste loss as a distinct symptom of COVID-19: a systematic review and meta-analysis.

Authors:  Mackenzie E Hannum; Riley J Koch; Vicente A Ramirez; Sarah S Marks; Aurora K Toskala; Riley D Herriman; Cailu Lin; Paule V Joseph; Danielle R Reed
Journal:  Chem Senses       Date:  2022-01-01       Impact factor: 3.160

2.  SARS-CoV-2, Zika viruses and mycoplasma: Structure, pathogenesis and some treatment options in these emerging viral and bacterial infectious diseases.

Authors:  Gonzalo Ferreira; Axel Santander; Florencia Savio; Mariana Guirado; Luis Sobrevia; Garth L Nicolson
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-09-03       Impact factor: 5.187

3.  SARS-CoV-2 in Environmental Samples of Quarantined Households.

Authors:  Manuel Döhla; Bianca Schulte; Gero Wilbring; Beate Mareike Kümmerer; Christin Döhla; Esther Sib; Enrico Richter; Patrick Frank Ottensmeyer; Alexandra Haag; Steffen Engelhart; Anna Maria Eis-Hübinger; Martin Exner; Nico Tom Mutters; Ricarda Maria Schmithausen; Hendrik Streeck
Journal:  Viruses       Date:  2022-05-17       Impact factor: 5.818

4.  On the usefulness of point-of-care antibody tests for severe acute respiratory syndrome coronavirus 2 in community screening settings.

Authors:  M Döhla; C Diegmann
Journal:  Public Health       Date:  2020-05-25       Impact factor: 2.427

5.  Taste loss as a distinct symptom of COVID-19: A systematic review and meta-analysis.

Authors:  Mackenzie E Hannum; Riley J Koch; Vicente A Ramirez; Sarah S Marks; Aurora K Toskala; Riley D Herriman; Cailu Lin; Paule V Joseph; Danielle R Reed
Journal:  medRxiv       Date:  2021-10-09

6.  Assessment of SARS-CoV-2 Infection among Healthcare Workers of a German COVID-19 Treatment Center.

Authors:  Lionel Larribère; Jelizaveta Gordejeva; Lisa Kuhnhenn; Maximilian Kurscheidt; Monika Pobiruchin; Dilyana Vladimirova; Maria Martin; Markus Roser; Wendelin Schramm; Uwe M Martens; Tatjana Eigenbrod
Journal:  Int J Environ Res Public Health       Date:  2021-07-01       Impact factor: 3.390

7.  Detectable SARS-CoV-2 RNAemia in Critically Ill Patients, but Not in Mild and Asymptomatic Infections.

Authors:  Enrico Richter; Doaa Al Arashi; Bianca Schulte; Christian Bode; Benjamin Marx; Souhaib Aldabbagh; Celina Schlüter; Beate Mareike Kümmerer; Johannes Oldenburg; Markus B Funk; Christian Putensen; Ricarda Maria Schmithausen; Gunther Hartmann; Anna Eis-Hübinger; Hendrik Streeck
Journal:  Transfus Med Hemother       Date:  2021-05-25       Impact factor: 3.747

8.  Outpatient Management of Oligosymptomatic Patients with respiratory infection in the era of SARS-CoV-2: Experience from rural German general practitioners.

Authors:  Simon Wernhart; Tim-Henning Förster; Eberhard Weihe
Journal:  BMC Infect Dis       Date:  2020-11-06       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.